UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

Drugs (New York, N.Y.), 2012-02, Vol.72 (3), p.309-325

2012

Volltextzugriff (PDF)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2017-10, Vol.27 (8), p.690-699

2017

Volltextzugriff (PDF)

Single-Dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-Release Chewable Tablet Compared With Immediate-Release Methylphenidate Chewable Tablet

Clinical therapeutics, 2016-05, Vol.38 (5), p.1151-1157

2016

Volltextzugriff (PDF)

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2018-06, Vol.28 (5), p.306-313

2018

Volltextzugriff (PDF)

Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole

Clinical therapeutics, 2018-05, Vol.40 (5), p.733-740

2018

Volltextzugriff (PDF)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study

Journal of child and adolescent psychopharmacology, 2018-06, Vol.28 (5), p.314-321

2018

Volltextzugriff (PDF)

Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD

Journal of attention disorders, 2017-12, Vol.21 (14), p.1180-1191

2017

Volltextzugriff (PDF)

NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study

Journal of child and adolescent psychopharmacology, 2013-02, Vol.23 (1), p.3-10

2013

Volltextzugriff (PDF)

Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study

BMC medicine, 2008-06, Vol.6 (1), p.17-17, Article 17

2008

Volltextzugriff (PDF)

4.7 EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S164-S165

2016

Volltextzugriff (PDF)

Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics

The journal of clinical psychiatry, 2004-08, Vol.65 (8), p.1084-1089

2004

Volltextzugriff (PDF)

The Single-Dose Pharmacokinetics of NWP06, a Novel Extended-Release Methylphenidate Oral Suspension

Postgraduate medicine, 2010-09, Vol.122 (5), p.35-41

2010

Volltextzugriff (PDF)

Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended‐Release Oral Suspension for Attention Deficit Hyperactivity Disorder

Clinical pharmacology in drug development, 2017-09, Vol.6 (5), p.476-483

2017

Volltextzugriff (PDF)

Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia

Journal of psychiatric research, 2008-10, Vol.42 (13), p.1076-1085

2008

Volltextzugriff (PDF)

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia

Biological psychiatry (1969), 1999-11, Vol.46 (10), p.1429-1435

1999

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD

Postgraduate medicine, 2011-09, Vol.123 (5), p.80-88

2011

Volltextzugriff (PDF)

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child and Adolescent Psychiatry, 2017-10, Vol.56 (10), p.S278-S279

2017

Volltextzugriff (PDF)

Recurrent Priapism During Treatment With Clozapine and Olanzapine

The American journal of psychiatry, 2000-04, Vol.157 (4), p.659-659

2000

Volltextzugriff (PDF)

Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder

The journal of clinical psychiatry, 2005-02, Vol.66 (2), p.205-212

2005

Volltextzugriff (PDF)

Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation

Critical reviews in neurobiology, 1998, Vol.12 (4), p.319-338

1998

Volltextzugriff (PDF)

Periodic catatonia: A case report and literature review

Schizophrenia research, 1997, Vol.24 (1), p.5-5

1997

Volltextzugriff (PDF)

Regulation of the internalization of the 5HT 2A receptor in vitro

Schizophrenia research, 1997, Vol.24 (1), p.90-90

1997

Volltextzugriff (PDF)

Regulation of the internalization of the 5HT2A receptor in vitro

Schizophrenia research, 1997-01, Vol.24 (1-2), p.90

1997

Volltextzugriff (PDF)

Effect of D 2 dopamine agonists on tuberoinfundibular dopamine neurons

Neuropharmacology, 1991, Vol.30 (9), p.961-965

1991

Volltextzugriff (PDF)

Evidence for protein kinase-C mediation of the neurotensin-induced activation of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons

Endocrinology (Philadelphia), 1992-09, Vol.131 (3), p.1207-1211

1992

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(197)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(274)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Single-Dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-Release Chewable Tablet Compared With Immediate-Release Methylphenidate Chewable Tablet

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study

Efficacy, Safety, and Tolerability of a Novel Methylphenidate Extended-Release Oral Suspension (MEROS) in ADHD

NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study

Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study

4.7 EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics

The Single-Dose Pharmacokinetics of NWP06, a Novel Extended-Release Methylphenidate Oral Suspension

Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended‐Release Oral Suspension for Attention Deficit Hyperactivity Disorder

Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia

Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Recurrent Priapism During Treatment With Clozapine and Olanzapine

Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder

Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation

Periodic catatonia: A case report and literature review

Regulation of the internalization of the 5HT 2A receptor in vitro

Regulation of the internalization of the 5HT2A receptor in vitro

Effect of D 2 dopamine agonists on tuberoinfundibular dopamine neurons

Evidence for protein kinase-C mediation of the neurotensin-induced activation of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons

Suchergebnisse filtern